Abstract:The study was designed to determine the role of long noncoding RNA (lncRNA), metastasis-associated lung adenocarcinoma transcript 1 (Malat1), in ischemic stroke outcome. Primary mouse brain microvascular endothelial cells (BMECs) were cultured and treated with Malat1 GapmeR before 16 h oxygen and glucose depravation (OGD). Cell death was assayed by LDH and MTT methods. Malat1 knock-out and wild-type mice were subjected to 1 h of middle cerebral artery occlusion (MCAO) and 24-72 h of reperfusion. To explore the underlying mechanism, apoptotic and inflammatory factors were measured by qPCR, ELISA, and Western blotting. The physical interaction between Malat1 and apoptotic or inflammatory factors was measured by RNA immunoprecipitation. Increased Malat1 levels were found in cultured mouse BMECs after OGD as well as in isolated cerebral microvessels in mice after MCAO. Silencing of Malat1 by Malat1 GapmeR significantly increased OGD-induced cell death and Caspase 3 activity in BMECs. Silencing of Malat1 also significantly aggravated OGD-induced expression of the proapoptotic factor Bim and proinflammatory cytokines MCP-1, IL-6, and E-selectin. Moreover, Malat1 KO mice presented larger brain infarct size, worsened neurological scores, and reduced sensorimotor functions. Consistent with in vitro findings, significantly increased expression of proapoptotic and proinflammatory factors was also found in the cerebral cortex of Malat1 KO mice after ischemic stroke compared with WT controls. Finally, we demonstrated that Malat1 binds to Bim and E-selectin both in vitro and in vivo Our study suggests that Malat1 plays critical protective roles in ischemic stroke.SIGNIFICANCE STATEMENT Accumulative studies have demonstrated the important regulatory roles of microRNAs in vascular and neural damage after ischemic stroke. However, the functional significance and mechanisms of other classes of noncoding RNAs in cerebrovascular pathophysiology after stroke are less studied. Here we demonstrate a novel role of Malat1, a long noncoding RNA that has been originally identified as a prognostic marker for non-small cell lung cancer, in cerebrovascular pathogenesis of ischemic stroke. Our experiments have provided the first evidence that Malat1 plays anti-apoptotic and anti-inflammatory roles in brain microvasculature to reduce ischemic cerebral vascular and parenchymal damages. Our studies also suggest that lncRNAs can be therapeutically targeted to minimize poststroke brain damage.

Long Non-Coding RNA Malat1 Regulates Angiogenesis in Hindlimb Ischemia

Long Noncoding Rna Malat1 Contributes To Inflammatory Response Of Microglia Following Spinal Cord Injury Via The Modulation Of A Mir-199b/Ikk Beta/Nf-Kb Signaling Pathway

Long non-coding RNA MALAT1 contributes to inflammatory response of microglia following spinal cord injury via modulating miR-199b/IKKβ/NF-κB signaling pathway.

Long Noncoding RNA Malat1 Regulates Cerebrovascular Pathologies in Ischemic Stroke

Long Noncoding RNA MALAT1 Participates in the Pathological Angiogenesis of Diabetic Retinopathy in an Oxygen-Induced Retinopathy Mouse Model by Sponging Mir-203A-3p

LncRNA MALAT1 Up-Regulates VEGF-A and ANGPT2 to Promote Angiogenesis in Brain Microvascular Endothelial Cells Against Oxygen–glucose Deprivation Via Targetting Mir-145

Long non-coding RNA MALAT1 enhances angiogenesis during bone regeneration by regulating the miR-494/SP1 axis

MALAT 1 upregulates VEGF-A and ANGPT 2 to promote angiogenesis in brain microvascular endothelial cells against oxygen-glucose deprivation via targeting miR-145 Running title : MALAT 1 promotes angiogenesis via targeting miR-145

LncRNA MALAT1 Promotes Tumor Angiogenesis by Regulating MicroRNA-150-5p/VEGFA Signaling in Osteosarcoma: In-Vitro and In-Vivo Analyses

The lncRNA Malat1 regulates microvascular function after myocardial infarction in mice via miR-26b-5p/Mfn1 axis-mediated mitochondrial dynamics

The Lncrna MALAT1 Protects the Endothelium Against Ox-Ldl-induced Dysfunction Via Upregulating the Expression of the Mir-22-3p Target Genes CXCR2 and AKT

LncRNA MALAT1 inhibits hypoxia/reoxygenationinduced human umbilical vein endothelial cell injury via targeting the microRNA-320a/RAC1 axis.

Long Non-Coding Rna Malat1 Sponges Mir-124-3p.1/Klf5 To Promote Pulmonary Vascular Remodeling And Cell Cycle Progression Of Pulmonary Artery Hypertension

The Role of the lncRNA MALAT1 in Neuroprotection against Hypoxic/Ischemic Injury

Targeting the Long Noncoding RNA MALAT1 Blocks the Pro-Angiogenic Effects of Osteosarcoma and Suppresses Tumour Growth

LncRNA MALAT1 modulates ox-LDL induced EndMT through the Wnt/β-catenin signaling pathway

Down-regulation of lncRNA MALAT1 alleviates vascular lesion and vascular remodeling of rats with hypertension

Malat1 Regulates Myogenic Differentiation and Muscle Regeneration Through Modulating MyoD Transcriptional Activity

Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus

Research Progress on a Long Non-coding RNA MALAT1

Long Non-coding RNAMALAT1 Knockdown Alleviates Cerebral Ischemia/Reperfusion Injury of Rats Through Regulating the miR-375/PDE4D Axis